{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:17:30Z","timestamp":1787761050341,"version":"build-2784847793"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Awake fiberoptic intubation (AFOI) is the gold standard for managing a difficult airway. To make the patient comfortable and cooperative during the procedure, many drugs such as benzodiazepines, opioids, or dexmedetomidine are used. Most of these intravenously given drugs may cause respiratory depression and hypoxia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>We compared the efficacy of dexmedetomidine through nebulization and transtracheal route with intravenous routes with the primary aim of comparing patient tolerance score (PTS) and secondary objectives of comparing sedation score, cough score, and total duration required for awake fiberoptic nasotracheal intubation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings and Design:<\/jats:title>\n                    <jats:p>This study was a prospective randomized double-blind study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects and Methods:<\/jats:title>\n                    <jats:p>\n                      Seventy-six patients, scheduled for elective surgery requiring AFOI between 18 and 75 years, were included in the study. They were randomly divided into two groups of 38 each. Group I patients received intravenous dexmedetomidine 1 \u03bcg.kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      and Group L patients received local dexmedetomidine through nebulization 0.5 \u03bcg.kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      and transtracheal injection 0.5 \u03bcg.kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>Statistical Package for the Social Sciences version 22 was used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Patients who received dexmedetomidine through nebulization and transtracheal route have significantly better PTSs and less cough scores as compared to patients who received dexmedetomidine by intravenous route (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). Hemodynamic parameters and sedation scores between the two groups were statistically insignificant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05). The time required for the procedure was significantly less in Group L compared to Group I (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Dexmedetomidine by nebulization and transtracheal route provides optimal conditions for AFOI with good patient tolerance and less cough score as compared to the intravenous route.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aer.aer_140_22","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T10:21:30Z","timestamp":1670581290000},"page":"407-411","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["A Comparative Study between Local Dexmedetomidine and Intravenous Dexmedetomidine during Awake Fiberoptic Nasotracheal Intubation"],"prefix":"10.4103","volume":"16","author":[{"given":"Abhay G.","family":"Sancheti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita S.","family":"Swami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta Laxmikant","family":"Konnur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nooh","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20240901","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/ALN.0000000000004002","article-title":"2022 American society of anesthesiologists practice guidelines for management of the difficult airway","volume":"136","author":"Apfelbaum","year":"2022","journal-title":"Anesthesiology"},{"key":"R2-23-20240901","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s12630-013-9915-9","article-title":"Conscious sedation for awake fibreoptic intubation: A review of the literature","volume":"60","author":"Johnston","year":"2013","journal-title":"Can J Anaesth"},{"key":"R3-23-20240901","first-page":"13","article-title":"Dexmedetomidine: A novel sedative-analgesic agent","volume":"14","author":"Gertler","year":"2001","journal-title":"Proc (Bayl Univ Med Cent"},{"key":"R4-23-20240901","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4103\/joacp.JOACP_242_16","article-title":"The efficacy of local dexmedetomidine during fiberoptic nasotracheal intubation: A randomized clinical trial","volume":"33","author":"Mirkheshti","year":"2017","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"R5-23-20240901","doi-asserted-by":"crossref","first-page":"157","DOI":"10.18231\/2394-4994.2019.0030","article-title":"A comparison of the effectiveness of dexmedetomidine versus propofol-fentanyl combination for sedation during awake fibreoptic nasotracheal intubation","volume":"6","author":"Mariyappa","year":"2019","journal-title":"Indian J Clinl Anaesth"},{"key":"R6-23-20240901","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3760\/cma.j.issn.0366-6999.2009.04.0010","article-title":"Clinical assessment of awake endotracheal intubation using the lightwand technique alone in patients with difficult airways","volume":"122","author":"Xue","year":"2009","journal-title":"Chin Med J (Engl"},{"key":"R7-23-20240901","first-page":"88","article-title":"Sedation scales and measures \u2013 A literature review","volume":"29","author":"Newton","year":"2013","journal-title":"SAAD Dig"},{"key":"R8-23-20240901","first-page":"92","article-title":"Awake fiberoptic intubation \u2013 Gold standard for the anticipated difficult airway","volume":"49","author":"Schenk","year":"2014","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"R9-23-20240901","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/anae.14904","article-title":"Difficult airway society guidelines for awake tracheal intubation (ATI) in adults","volume":"75","author":"Ahmad","year":"2020","journal-title":"Anaesthesia"},{"key":"R10-23-20240901","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4103\/0970-9185.155151","article-title":"Comparison between dexmedetomidine and fentanyl on intubation conditions during awake fiberoptic bronchoscopy: A randomized double-blind prospective study","volume":"31","author":"Mondal","year":"2015","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"R11-23-20240901","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4103\/ija.IJA_320_19","article-title":"Attenuation of haemodynamic responses to laryngoscopy and endotracheal intubation with dexmedetomidine: A comparison between intravenous and intranasal route","volume":"63","author":"Niyogi","year":"2019","journal-title":"Indian J Anaesth"},{"key":"R12-23-20240901","doi-asserted-by":"crossref","first-page":"874","DOI":"10.4103\/ija.IJA_235_20","article-title":"Evaluation of nebulised dexmedetomidine in blunting haemodynamic response to intubation: A prospective randomised study","volume":"64","author":"Kumar","year":"2020","journal-title":"Indian J Anaesth"},{"key":"R13-23-20240901","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tacc.2020.09.009","article-title":"Fentanyl versus dexmedetomidine nebulization as adjuvant to lignocaine: A comparative study during awake flexible fiberoptic bronchoscopy","volume":"37","author":"Kumari","year":"2021","journal-title":"Trends Anaesth Crit Care"}],"container-title":["Anesthesia Essays &amp; Researches"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aer.aer_140_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:17:42Z","timestamp":1787757462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aer.aer_140_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/aer.aer_140_22","relation":{},"ISSN":["0259-1162"],"issn-type":[{"value":"0259-1162","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}